Apart from the influence of triglycerides, the GCKR variant, which was reported to be associated with decreased risk of T2DM but increased risk of dyslipidemia and fatty liver disease [43], may also play an important role to explain the pleiotropic pathways been identified. This evidence concerns the gene GCKR and metabolic syndrome.